Advertisement

Topics

Gout & Uric Acid Education Society Company Profile

16:48 EDT 19th March 2019 | BioPortfolio

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and healthcare providers. For more information about gout and the Gout & Uric Acid Education Society, please visit www.gouteducation.org. Gout Awareness Day is sponsored by Ardea Biosciences, Inc., EnzymeRx, LLC., Novartis Pharmaceutical Corp; Savient Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc. and URL Pharma.


News Articles [1467 Associated News Articles listed on BioPortfolio]

Mortality Risk Doubles for Gout When Uric Acid Not Optimal

Risk for death doubles when gout patients fail to achieve optimal levels of serum uric acid, new research shows, so treatment to target is essential. Medscape Medical News

Alternatives to specific uric acid lowering treatment in gout in patients with cardiovascular disease

As with the response from Charkin to the latest guidance on the management of gout, as a GP I frequently see patients with gout who have cardiovascular risk factors.12As mentioned in the article some....

Gout Risk Factor Less about Diet, More about Genes

Despite accumulating evidence that gout isn’t all about diet, the condition retains its reputation as the “rich man’s disease”—or the disease that afflicts those who eat richly, regardless o...

Gout, Like RA, Has Evolved as a Systemic Threat

Risk for death doubles when gout patients fail to achieve optimal levels of serum uric acid, new research shows, so treatment to target is essential. Medscape Medical News

Gout Attack Risk Lowered With Interleukin-1ß Blockade

Inhibition of IL-1ß with canakinumab significantly decreased gout attack risk at all baseline serum uric acid (SUA) levels and without changing SUA levels.

Quarterly canakinumab administration associated with significantly reduced risk for gout attacks

1. Use of canakinumab was associated with reduced risk for gout attacks. 2. Canakinumab administration did not result in changes to serum uric acid levels. Evidence Rating Level: 1 (Excellent) Study R...

Canakinumab Reduces Gout Risk Without Changing SUA Levels

Canakinumab, an interleukin 1bea blocker, was associated with significantly lower risk for gout attacks when given quarterly, but did not change serum uric acid levels, a study has found. Medscape M...

Uric Acid Test

Source: National Library of Medicine - Related MedlinePlus Pages: Gout, Kidney Stones

Drugs and Medications [176 Associated Drugs and Medications listed on BioPortfolio]

Elitek [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use ELITEK safely and effectively. See full prescribing information for ELITEK. ELITEK (rasburicase) for injection, for intravenous useIn...

Pyrazinamide [a-s medication solutions]

PYRAZINAMIDE TABLETS, USP 500 mg Rx Only

Pyrazinamide [remedyrepack inc.]

PYRAZINAMIDE TABLETS, USP 500 mg Rx Only

Pyrazinamide [major pharmaceuticals]

PYRAZINAMIDE TABLETS, USP 500 mg Rx Only

Pyrazinamide [a-s medication solutions]

PYRAZINAMIDE TABLETS USP, 500 mg

PubMed Articles [3809 Associated PubMed Articles listed on BioPortfolio]

Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.

Although studies have shown that interleukin-1β (IL-1β) inhibitors can shorten gout attacks, whether they can prevent gout attacks is unclear.

Moving the Needle: Improving the Care of the Gout Patient.

Gout is a the most common inflammatory arthritis in the United States. It is a significant cause of morbidity, disability, lost work days, and high healthcare utilization due to intermittent attacks, ...

The Association Between Serum Uric Acid Level and Prognosis in Critically Ill Patients, Uric Acid as a Prognosis Predictor.

Uric acid is synthesized from xanthine via xanthine oxidase as an end-product of purine metabolism. Uric acid is a major non-enzymatic antioxidant in the blood, and it exerts a protective action on vi...

The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2.

Gout, a common and complex form of inflammatory arthritis, is characterized by abnormally elevated levels of uric acid in the blood. The most current estimate from the Centers for Disease Control and ...

The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout.

The NLRP3 inflammasome is implicated in the processing of the pro-inflammatory cytokine interleukin 1β. Inflammatory disorders associated with the activation of the NLRP3 inflammasome - IL-1 axis are...

Clinical Trials [5714 Associated Clinical Trials listed on BioPortfolio]

The Diet Gout Trial

Unhealthy diet has long been associated with high uric acid levels and gout. The DASH diet may lower uric acid levels. This study will examine the effects of the DASH diet on uric acid in ...

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

To investigate the pharmacodynamics and safety of FYU-981 administered orally once a day for 14 weeks, to uric acid-overproduction type or uric acid-underexcretion type of male hyperuricem...

Optimal Administration of Allopurinol in Dialysis Patients

Gout has a strong association with the metabolic syndrome, and it is often seen in patients with renal insufficiency. Allopurinol is a medication intended to lower uric acid and therefore ...

Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout

The purpose of this study is to determine whether PEG-uricase (a chemically modified recombinant mammalian enzyme that degrades uric acid) is effective in controlling hyperuricemia in pati...

A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy

This is a randomized, open-label, multicenter, parallel-groups study of multiple intravenous doses of Puricase, administered intravenously, in 40 patients with symptomatic gout. Subjects m...

Companies [1977 Associated Companies listed on BioPortfolio]

The Gout & Uric Acid Education Society

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and health care ...

Gout & Uric Acid Education Society

Formed in September 2005, the Gout & Uric Acid Education Society has a comprehensive educational brochure, as well as a user-friendly Web site for patients, caregivers, family members and healthcare p...

Mountain View Pharmaceuticals, Inc.

MVP is a privately-held California corporation with expertise in the application of advanced polymer-coupling technology to make protein-based drugs safer and longer acting. To da...

The Gerontological Society of America

The Gerontological Society of America (GSA) is the nation's oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of a...

Professor Ona's laboratory at Kyushu University

Started in beginning of 2002, Professor Ona's laboratory develops original theories, instruments and applications concerning human health, ES cell differentiation, aquaculture, en...

More Information about "Gout & Uric Acid Education Society" on BioPortfolio

We have published hundreds of Gout & Uric Acid Education Society news stories on BioPortfolio along with dozens of Gout & Uric Acid Education Society Clinical Trials and PubMed Articles about Gout & Uric Acid Education Society for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gout & Uric Acid Education Society Companies in our database. You can also find out about relevant Gout & Uric Acid Education Society Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record